iPSCs to the rescue in Alzheimer's research
- PMID: 22385650
- DOI: 10.1016/j.stem.2012.02.011
iPSCs to the rescue in Alzheimer's research
Abstract
A crucial limitation to our understanding of Alzheimer's disease has been the inability to test hypotheses on live, patient-specific neurons. A recent study in Nature by Israel et al. (2012) reports that iPSC-derived neurons from AD patients recapitulate multiple aspects of disease pathology.
Copyright © 2012 Elsevier Inc. All rights reserved.
Comment on
-
Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells.Nature. 2012 Jan 25;482(7384):216-20. doi: 10.1038/nature10821. Nature. 2012. PMID: 22278060 Free PMC article.
Similar articles
-
Capturing Alzheimer's disease genomes with induced pluripotent stem cells: prospects and challenges.Genome Med. 2011 Jul 27;3(7):49. doi: 10.1186/gm265. Genome Med. 2011. PMID: 21867573 Free PMC article.
-
[Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].Glas Srp Akad Nauka Med. 2011;(51):85-97. Glas Srp Akad Nauka Med. 2011. PMID: 22165729 Review. Serbian.
-
A 3D Alzheimer's disease culture model and the induction of P21-activated kinase mediated sensing in iPSC derived neurons.Biomaterials. 2014 Feb;35(5):1420-8. doi: 10.1016/j.biomaterials.2013.11.028. Epub 2013 Nov 27. Biomaterials. 2014. PMID: 24290439
-
Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness.Cell Stem Cell. 2013 Apr 4;12(4):487-96. doi: 10.1016/j.stem.2013.01.009. Epub 2013 Feb 21. Cell Stem Cell. 2013. PMID: 23434393
-
Stem-cell challenges in the treatment of Alzheimer's disease: a long way from bench to bedside.Med Res Rev. 2014 Sep;34(5):957-78. doi: 10.1002/med.21309. Epub 2014 Feb 5. Med Res Rev. 2014. PMID: 24500883 Review.
Cited by
-
Culture Variabilities of Human iPSC-Derived Cerebral Organoids Are a Major Issue for the Modelling of Phenotypes Observed in Alzheimer's Disease.Stem Cell Rev Rep. 2022 Feb;18(2):718-731. doi: 10.1007/s12015-021-10147-5. Epub 2021 Mar 16. Stem Cell Rev Rep. 2022. PMID: 33725267
-
Early pathogenic event of Alzheimer's disease documented in iPSCs from patients with PSEN1 mutations.Oncotarget. 2017 Jan 31;8(5):7900-7913. doi: 10.18632/oncotarget.13776. Oncotarget. 2017. PMID: 27926491 Free PMC article.
-
Alzheimer's in 3D culture: challenges and perspectives.Bioessays. 2015 Oct;37(10):1139-48. doi: 10.1002/bies.201500063. Epub 2015 Aug 7. Bioessays. 2015. PMID: 26252541 Free PMC article. Review.
-
Human Neurospheroid Arrays for In Vitro Studies of Alzheimer's Disease.Sci Rep. 2018 Feb 5;8(1):2450. doi: 10.1038/s41598-018-20436-8. Sci Rep. 2018. PMID: 29402979 Free PMC article.
-
Overcoming translational barriers impeding development of Alzheimer's disease modifying therapies.J Neurochem. 2016 Oct;139 Suppl 2(Suppl 2):224-236. doi: 10.1111/jnc.13583. Epub 2016 May 4. J Neurochem. 2016. PMID: 27145445 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources